Liquid Biopsy Has Mixed Performance for Predicting Colon Cancer Outcomes
SAN FRANCISCO — In separate studies, liquid biopsy produced mixed results for guiding colon cancer treatment. Adjuvant chemotherapy guided by postoperative circulating tumor (ct) DNA did not lead to higher rates of DNA clearance as compared with patients who did not get chemotherapy. However, ctDNA did show promise for identifying patients with molecular residual disease […]